Shockwave Therapy Device

The United States Special Operations Command, specifically Naval Special Warfare (NSW) Command, is seeking to procure a Storz DuoLith Ultra Device, a specialized radial pulsed wave and focused shockwave therapy device for medical treatment. This brand-specific acquisition is intended to support musculoskeletal condition treatments in naval medical facilities, with a requirement for a compact device capable of performing multiple therapy modalities. The procurement will be conducted under FAR Part 12 and Part 13, utilizing commercial product acquisition procedures. The contract will be a Firm Fixed Price (FFP) purchase order type, with a North American Industry Classification System (NAICS) code of 334510. The pre-solicitation notice was posted on May 14, 2025, with responses due by May 21, 2025, indicating a short response window for potential vendors.

The opportunity is designated as a 100% small business set-aside, with a size standard of 1,250 employees for the specified NAICS category of Electromedical and Electrotherapeutic Apparatus Manufacturing. The procurement is justified through a brand-name exception, as the Storz DuoLith Ultra is the only known device offering both radial and focused shockwave therapy in a single combined unit. While specific award value details are not explicitly stated, the procurement is for a single device with precise specifications for naval medical use. The government has prepared a Sole or Limited Sources Justification document that outlines the specific requirements and rationale for the brand-specific procurement. Potential vendors should carefully review the attached documentation and be prepared to meet the stringent technical and commercial requirements for this specialized medical device acquisition.